HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.

HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.

Anti-HER2/neu antibody therapy has been reported to mediate tumor regression of HER2/ neu(+) tumors. Here we demonstrated the expression of HER2 in a wide range of human melanoma cells including a primary culture and seven cell lines, and we further investigated whether HER2 could be served as a tar...

Full description

Bibliographic Details
Main Authors: Juan Ma, Huamin Han, Deruo Liu, Wei Li, Hongxiang Feng, Xin Xue, Xiaoran Wu, Ge Niu, Ge Zhang, Yunfeng Zhao, Changzhen Liu, Hua Tao, Bin Gao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3754977?pdf=render

Internet

http://europepmc.org/articles/PMC3754977?pdf=render

Similar Items